Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Clinical trial NCT06865651 · RECRUITING
Trial details
- NCT number
- NCT06865651
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2027-08-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.